Viewing nowGlipide Tablets 2mg (Glimepiride)
Glimepiride 2mg
Tablet · Prescription medication
Huons Bio Science Co., Ltd.

MFDS item code 200404740 · Notified 2004.06.26 · Insurance code 052700010
Improvement of blood glucose control in type 2 diabetes mellitus
This medication helps patients with type 2 diabetes improve their blood sugar control alongside dietary and exercise therapies. It can be used as monotherapy, and can also be combined with insulin when oral hypoglycemic agents do not achieve sufficient control. Additionally, for patients whose blood sugar cannot be controlled with sulfonylureas or metformin monotherapy, combining it with metformin can enhance blood sugar management. Overall, this medication is effectively used to improve blood sugar control in patients with type 2 diabetes.
Adjust the dosage individually for each patient. Swallow whole without chewing, with at least 1/2 cup of water. This medicine is taken orally once daily. This medicine should be taken before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose titration For patients who have not previously received drug therapy, start treatment with glimepiride 1 mg once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, doses above 4 mg provide little additional benefit, although some patients have shown better metabolic control when the dose was increased to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic drug. 2) Subsequent dose adjustment As diabetes control improves during treatment, the need for this medicine may decrease. Therefore, dose reduction or discontinuation of this medicine may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, changes in lifestyle, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral blood glucose-lowering agent to this medicine There is no precise dose-equivalence relationship between this medicine and other oral blood glucose-lowering agents. When switching from another oral blood glucose-lowering agent to this medicine, it is recommended to follow the method described under Initial dose. That is, start treatment with 1 mg daily and adjust the dose at intervals of 1 ~ 2 weeks. The potency and duration of action of the previously administered drug should be taken into consideration. 4) Dose adjustment during treatment While taking this medicine, blood glucose and/or urine glucose levels should be measured regularly; regular measurement of glycated hemoglobin (HbA1c) levels is also recommended. In general, hypoglycemia can be promptly managed by consuming sugar. Hypoglycemia may recur even after it has been successfully managed initially during treatment with a sulfonylurea. Therefore, patients should be monitored carefully. Severe hypoglycemia requires immediate treatment and follow-up by a physician, and hospitalization is sometimes required. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this medicine and insulin is used in patients with secondary failure, and should be used when fasting blood glucose (FBG) exceeds 150 mg/dL. This medicine is given at a dose of 8 mg once daily with the first meal, while insulin is started at a low dose and increased approximately weekly according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. The insulin dose should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, adding metformin may be considered. Published clinical information is available on combination therapy with metformin and other sulfonylurea agents, such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this medicine is used in combination with metformin, the desired blood glucose level may be achieved by adjusting the dose of each drug. However, efforts should be made to determine the minimum effective dose of each drug for blood glucose control. There is a risk of hypoglycemia when this medicine is administered in combination with metformin, and the risk may increase. Appropriate precautions should be taken.
This medication should not be used in patients with insulin-dependent diabetes or severe liver or kidney dysfunction. Additionally, it should not be taken by patients who have had allergic reactions to this medication or similar drugs, or by women who are pregnant or breastfeeding. In cases of severe infections or major surgery, or severe trauma, switching to insulin treatment is recommended. Care should be taken in cases of gastrointestinal disorders such as diarrhea or vomiting, as these can affect drug absorption. Patients with lactose intolerance or certain genetic metabolic disorders should not take this medication. During the first week of taking the medication, there is a high risk of hypoglycemia, so blood sugar levels must be closely monitored. The risk of hypoglycemia also increases in cases of poor nutritional status, irregular meals, excessive physical activity, or changes in eating patterns. Frequent alcohol consumption, decreased kidney and liver function, older age, and other endocrine disorders also require caution. If this medication has been overdosed or taken with other drugs, it may impact blood sugar control due to drug interactions, so it is essential to consult a physician. Symptoms of hypoglycemia can include headache, severe hunger, dizziness, confusion, drowsiness, and in severe cases, loss of consciousness, so it is crucial to recognize these symptoms and immediately consume sugar. Various side effects such as visual disturbances, dyspepsia, abnormal liver function, blood abnormalities, and allergic reactions may occur, and any abnormal symptoms should be discussed with healthcare providers immediately. The effectiveness of this medication is enhanced when taken regularly along with dietary and exercise therapies, and it is important to consume sugar immediately in cases of hypoglycemia. Women who are pregnant or planning to become pregnant, as well as those who are breastfeeding, are advised to consider insulin treatment instead of this medication. In cases of overdose, appropriate emergency measures such as inducing vomiting, gastric lavage, glucose injection, etc., are necessary, and monitoring is required for at least 24 to 48 hours to prevent recurrence of hypoglycemia. The safety and efficacy of this medication have not been established in children, and in elderly patients, dosage adjustments may be necessary considering renal function. Store the medication out of reach of children, keep it in its original container, and avoid transferring it to other containers.
Hypoglycemia, headache, severe hunger, nausea, vomiting, fatigue, sleep, sleep disorders, anxiety, aggressiveness, decreased concentration, reduced agility or motivation, depression, confusion, speech abnormalities, aphasia, visual disturbances, tremors, incomplete paralysis, sensory disturbances, dizziness, weakness, loss of self-control, temporary mental disturbance, seizures, drowsiness, loss of consciousness, coma, shallow breathing, bradycardia, sweating, cold and clammy skin, tachycardia, hypertension, palpitations, angina, deep vein thrombosis, blurred vision, fullness or pressure sensation in the upper abdomen, abdominal pain, diarrhea, increased liver enzymes, abnormal liver function, bile secretion disorders, jaundice, hepatitis, thrombocytopenia, leukopenia, hemolytic anemia, erythropenia, neutropenia, agranulocytosis, pancytopenia, itching, hives, rash, dyspnea, hypotension, shock, anaphylaxis, angioedema, Stevens-Johnson syndrome, allergic vasculitis, photosensitivity reactions of the skin, decreased serum sodium concentration, taste disturbances, hair loss, weight gain, dizziness, abnormal liver function, abdominal pain, arthralgia, dyspepsia, facial swelling, erectile dysfunction, facial flushing, gastritis
Not everyone experiences these, and they can vary from person to person.
This medication must be stored in a tightly sealed container to prevent exposure to air or moisture. It should also be stored at room temperature between 1°C and 30°C.
Green rectangular tablets
30 tablets/bottle, 200 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowGlimepiride 2mg
Tablet · Prescription medication
Huons Bio Science Co., Ltd.

Glimepiride 1mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 4mg
Tablet · Prescription medication
(Hanmi Pharmaceutical Co., Ltd.)

Glimepiride 2mg
Tablet · Prescription medication
Seoul Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
IYun Pharmaceuticals Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.